Segui
Lois Mulligan
Lois Mulligan
Cancer Research Institute, Queen's University
Email verificata su queensu.ca
Titolo
Citata da
Citata da
Anno
Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A
LM Mulligan, JBJ Kwok, CS Healey, MJ Elsdon, C Eng, E Gardner, ...
Nature 363 (6428), 458-460, 1993
24111993
The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2: International RET Mutation Consortium analysis
C Eng, D Clayton, I Schuffenecker, G Lenoir, G Cote, RF Gagel, ...
Jama 276 (19), 1575-1579, 1996
14321996
Mutations of the RET proto-oncogene in Hirschsprung’s disease
MA • Edery P, Lyonnet S, Mulligan LM, Pelet A, Dow E, Abel L, Holder S ...
Nature 367, 378-380, 1994
1149*1994
Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease
G Romeo, P Ronchetto, Y Luo, V Barone, M Seri, I Ceccherini, B Pasini, ...
Nature 367 (6461), 377-378, 1994
8761994
Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC
LM Mulligan, C Eng, CS Healey, D Clayton, JBJ Kwok, E Gardner, ...
Nature genetics 6 (1), 70-74, 1994
7881994
Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours
C Eng, DP SmIth, LM MullIgan, MA Nagal, CS Healey, MA Ponder, ...
Human molecular genetics 3 (2), 237-241, 1994
6271994
RET revisited: expanding the oncogenic portfolio
LM Mulligan
Nature Reviews Cancer 14 (3), 173-186, 2014
5352014
Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast
A Perren, LP Weng, AH Boag, U Ziebold, K Thakore, PLM Dahia, ...
The American journal of pathology 155 (4), 1253-1260, 1999
5291999
Diversity of RET proto-oncogene mutations in familial and sporadic Hirschsprung disease
T Attié, A Pelet, P Edery, C Eng, LM Mulligan, J Amiel, L Boutrand, ...
Human molecular genetics 4 (8), 1381-1386, 1995
3881995
Diversity of RET proto-oncogene mutations in familial and sporadic Hirschsprung disease
T Attié, A Pelet, P Edery, C Eng, LM Mulligan, J Amiel, L Boutrand, ...
Human molecular genetics 4 (8), 1381-1386, 1995
3881995
Mechanisms of p53 loss in human sarcomas.
LM Mulligan, GJ Matlashewski, HJ Scrable, WK Cavenee
Proceedings of the National Academy of Sciences 87 (15), 5863-5867, 1990
3381990
Genotype‐phenotype correlation in multiple endocrine neoplasia type 2: report of the International RET Mutation Consortium
LM Mulligan, DJ Marsh, BG Robinson, I Schuffenecker, J Zedenius, ...
Journal of internal medicine 238 (4), 343-346, 1995
3371995
A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC.
C Eng, DP Smith, LM Mulligan, CS Healey, MJ Zvelebil, TJ Stonehouse, ...
Oncogene 10 (3), 509-513, 1995
3211995
Multiple endocrine neoplasia type 2 andRET: from neoplasia to neurogenesis
JR Hansford, LM Mulligan
Journal of medical genetics 37 (11), 817-827, 2000
3122000
Analysis of PTEN and the 10q23 region in primary prostate carcinomas
HE Feilotter, MA Nagai, AH Boag, C Eng, LM Mulligan
Oncogene 16 (13), 1743-1748, 1998
2951998
Diverse phenotypes associated with exon 10 mutations of the RET proto-oncogene
LM Mulligan, C Eng, T Attlé, S Lyonnet, DJ Marsh, VJ Hyland, ...
Human Molecular Genetics 3 (12), 2163-2168, 1994
2931994
Germline Dinucleotide Mutation in Codon 883 of the RETProto-Oncogene in Multiple Endocrine Neoplasia Type 2B Without Codon 918 Mutation
O Gimm, DJ Marsh, SD Andrew, A Frilling, PLM Dahia, LM Mulligan, ...
The Journal of Clinical Endocrinology & Metabolism 82 (11), 3902-3904, 1997
2811997
Mutations of the RET proto‐oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and Hirschsprung disease
C Eng, LM Mulligan
Human mutation 9 (2), 97-109, 1997
2701997
Characterization of RET proto-oncogene 3'splicing variants and polyadenylation sites: a novel C-terminus for RET.
SM Myers, C Eng, BA Ponder, LM Mulligan
Oncogene 11 (10), 2039-2045, 1995
2381995
Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas.
C Eng, PA Crossey, LM Mulligan, CS Healey, C Houghton, A Prowse, ...
Journal of Medical Genetics 32 (12), 934-937, 1995
2261995
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20